A source close to the toy industry has leaked a copy of Santa’s perks list for Wisconsin politicians, business leaders and ...
Polaris Capital Management, an investment management company, released its third quarter 2024 investor letter. A copy of the ...
Recently AbbVie closed its acquisition of Aliada Therapeutics, including a promising Alzheimer's disease candidate, for $1.4 ...
Recently AbbVie closed its acquisition of Aliada Therapeutics, including a promising Alzheimer's disease candidate, for $1.4 billion in cash. And it announced that it will buy out Nimble ...
Hosted on MSN17d
Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A DealsPfizer PFE issued its financial guidance for 2025. Sanofi SNY and Teva Pharmaceutical’s TEVA inflammatory bowel disease (IBD) ...
AbbVie, a global pharmaceutical company headquartered in North Chicago, is acquiring Madison-based Nimble Therapeutics for $200 million in cash, the companies said in a news release. AbbVie has ...
On December 18, a recent SEC filing unveiled that Kevin K Buckbee, SVP at AbbVie ABBV made an insider sell. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on ...
AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out daily tasks such as eating and walking, months after the drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback